process for the manufacture of tablets with delayed release of one or more active substances present in the tablet.

• 1. 一种在胃液中漂浮并多脉冲释放活性物质的药用片剂系统、该系统和该系统包封物的制备方法 [P] . 中国专利： CN100589793C . 2010.02.17
• 2. 一种在胃液中漂浮并多脉冲释放活性物质的药用片剂系统、该系统和该系统包封物的制备方法 [P] . 中国专利： CN1499961A . 2004-05-26
• 3. process for the manufacture of tablets with delayed release of one or more active substances present in the tablet. [P] . 德国专利： DE2126810C3 . 1980-11-20

  机译： 延迟释放存在于片剂中的一种或多种活性物质的片剂的制备方法。

• 4. process for the manufacture of tablets with delayed release of one or more active substances present in the tablet. [P] . 法国专利： FR2104754B1 . 1975-08-01

  机译： 延迟释放存在于片剂中的一种或多种活性物质的片剂的制备方法。

• 5. process for the manufacture of tablets with delayed release of one or more active substances present in the tablet. [P] . DK130387B . 1975-02-17

  机译： 延迟释放存在于片剂中的一种或多种活性物质的片剂的制备方法。

• 1. Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system [J] . Yan Wang, Ping-Ping Xu, Xin-Xia Li, 西安医科大学学报(英文版) . 2012,第005期
• 2. Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system [J] . Yan Wang, Ping-Ping Xu, Xin-Xia Li, 药物分析学报（英文） . 2012,第005期
• 3. Analytical method development of pregabalin and related substances in extended release tablets containing polyethylene oxide [J] . Jin Seob Oh, Seo Hyun Lim, Sung Ha Ryu, 亚洲药物制剂科学(英文) . 2016,第001期
• 4. Characterisation of a novel, multifunctional, co-processed excipient and its effect on release profile of paracetamol from tablets prepared by direct compression [J] . Eraga Sylvester Okhuelegbe, Arhewoh Matthew Ikhuoria, Uhumwangho Michael Uwumagbe, 亚太热带生物医学杂志（英文版） . 2015,第009期
• 5. Characterisation of a novel, multifunctional, co-processed excipient and its effect on release profile of paracetamol from tablets prepared by direct compression [J] . Eraga, Sylvester, Okhuelegbe, 亚太热带生物医学杂志：英文版 . 2015,第009期
• 6. Development of a Robust Formulation and Manufacturing Process for HPMC-Based MatrixControlled Release Coated Tablets Made by Roller Compaction [C] . Vishal K. Gupta, David R. Langdon, Brian K. Cheng, Annual meeting exposition of the Controlled Release Society . 2005
• 7. 1. A novel self-sealing chewable sustained release tablet of acetaminophen, 2. Development and evaluation of novel itraconazole oral formulations, 3. A novel zero order release matrix tablet. [D] . Rakkanka, Vipaporn. 2003
• 8. Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared with 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial [O] . Stephen B Hanauer, William J Sandborn, Christian Dallaire, 2007
• 9. Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared with 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial [O] . Hanauer, Stephen B, Sandborn, William J, Dallaire, Christian, 2007
• 10. Rocket Tablet. [R] . Lixian, W. 1984

• 1. 顺序注射分析用于片剂释放度的在线测定以及阿司匹林释放动力学的研究 [C] . 王晋 ,刘学著 ,方群 . 2000中国药学会学术年会 . 2000
• 2. 六西格玛管理在片剂生产场地变更中质量评价的研究 [A] . 周美丽 . 2016